U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
Pfizer Shares Are Down Today: What's Going On?
Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating ...
Zacks Investment Research on MSN2d
Pfizer Is a Dirt-Cheap High-Yield Stock, But Is It a Buy?
Of late, pharmaceutical behemoth Pfizer Inc.’s PFE stock has struggled, but it remains a bargain with generous dividends. Its ...
Pharmaceutical Stocks To Consider – March 25th
Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...
STAT5d
Pfizer’s Wall Street critic-turned-executive digs into the company’s problems, obesity plans
Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...
Pfizer Is Now a High-Yield Bargain Stock
Pfizer's stock has recently struggled but remains a bargain with generous dividends. Is now a good time to invest in PFE?
Pfizer Is Trading As If It's 2009 Again
Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...
CMSWire14h
How Pfizer Is Building Customer Experience From the Inside Out
An exclusive interview with Pfizer’s Wayne Simmons on reshaping customer experience by listening to those interacting with ...
Pfizer: Undervalued Defensive Play
With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...